V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010291 | 280005674 | 1.73 | 70.6 | Palliative (P) | 2017-09-15 | 2018-05-21 | CAV | N | N | 280027748 | CAV |
| 280010292 | 280005678 | null | null | Adjuvant (A) | 2018-10-21 | 2018-10-27 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280027755 | GEMCITABINE |
| 280010293 | 280005680 | null | 73 | Palliative (P) | 2016-08-30 | 2016-09-13 | FLUOROURACIL + IRINOTECAN | 02 | N | 280027757 | IRINOTECAN + TEMOZOLOMIDE |
| 280010294 | 280005682 | null | null | Curative (C) | 2017-03-26 | 2017-03-26 | CISPLATIN + FLUOROURACIL | N | null | 280027762 | CISPLATIN + FLUOROURACIL |
| 280010295 | 280005686 | 1.73 | null | Palliative (P) | 2013-10-06 | 2013-10-09 | Carboplatin + Etoposide IV 3 day | 2 | N | 280027766 | CARBOPLATIN + ETOPOSIDE |
| 280010296 | 280005687 | 1.85 | 72.4 | Palliative (P) | null | 2015-11-26 | DE-ESCALATE TRIAL | N | N | 280027768 | DE-ESCALATE TRIAL |
| 280010297 | 280005690 | 1.68 | 61.3 | Palliative (P) | 2018-08-26 | 2018-09-08 | CISPLATIN + FLUOROURACIL | N | N | 280027776 | CISPLATIN + FLUOROURACIL |
| 280010298 | 280005692 | 1.65 | 54.2 | Palliative (P) | 2016-08-27 | 2016-10-06 | DE-ESCALATE TRIAL | 02 | N | 280027776 | DE-ESCALATE TRIAL |
| 280010299 | 280008984 | 1.67 | 55.9 | Curative (C) | 2015-10-11 | 2018-02-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 280027795 | CISPLATIN + GEMCITABINE |
| 280010300 | 280005694 | 1.79 | null | Curative (C) | 2017-12-22 | 2017-12-22 | VAC | N | N | 280027801 | CAV |
| 280010301 | 280005698 | 1.73 | 72.4 | Palliative (P) | 2014-12-12 | 2014-12-31 | Doxorubicin + Ifosfamide | N | N | 280027817 | DOXORUBICIN + IFOSFAMIDE |
| 280010302 | 280005702 | 1.62 | 54 | Adjuvant (A) | 2017-01-13 | 2017-01-13 | Cisplatin +Fluorouracil (2 wk) | N | N | 280027820 | CISPLATIN + FLUOROURACIL |
| 280010303 | 280005703 | 1.59 | 44.8 | Curative (C) | 2019-01-16 | 2019-01-17 | EW EuroEwing 2012 Arm A VIDE | N | N | 280027820 | EURO-EWING |
| 280010304 | 280005706 | 1.88 | 86.4 | Curative (C) | 2018-03-06 | 2018-07-19 | Oxaliplatin + Modified de Gramont | N | N | 280027833 | OXALIPLATIN + MDG |
| 280010305 | 280005706 | 1.65 | 56 | Palliative (P) | 2014-02-01 | 2014-02-23 | Doxorubicin + Olaratumab | 02 | null | 280027833 | DOXORUBICIN + OLARATUMAB |
| 280010306 | 280008994 | 1.7 | 76 | Disease modification (D) | 2017-08-14 | 2017-08-22 | DE-ESCALATE TRIAL | N | N | 280027850 | DE-ESCALATE TRIAL |
| 280010307 | 280005711 | 1.68 | 74.1 | Palliative (P) | 2017-08-03 | 2018-01-20 | Cisplatin+Gemcitabine (gallbladder) | N | N | 280027851 | CISPLATIN + GEMCITABINE |
| 280010308 | 280005712 | 1.77 | 86 | Palliative (P) | null | 2018-11-18 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | null | null | 280027853 | IRINOTECAN + TEMOZOLOMIDE |
| 280010309 | 280008998 | 1.7 | 91 | Palliative (P) | 2013-04-07 | 2016-01-19 | Irinotecan + Temozolomide | 02 | N | 280027858 | VAI |
| 280010310 | 280009000 | 1.63 | 98 | Disease modification (D) | 2018-09-27 | 2018-10-07 | CISPLATIN + FLUOROURACIL | N | N | 280027865 | CISPLATIN + FLUOROURACIL |
| 280010311 | 280005719 | 1.7 | 63.2 | Palliative (P) | 2016-07-21 | 2016-07-31 | EW EuroEwing 99 : VActI | 02 | N | 280027865 | EURO-EWING |
| 280010312 | 280005720 | 1.82 | null | Curative (C) | 2017-04-09 | 2017-06-05 | Cyclophosphamide oral | 02 | Y | 280027876 | CYCLOPHOSPHAMIDE |
| 280010313 | 280005721 | 0 | null | Adjuvant (A) | 2017-05-26 | 2017-05-26 | VAC | N | N | 280027877 | CAV |
| 280010314 | 280005722 | 1.76 | null | Palliative (P) | 2014-03-23 | 2014-04-16 | EURO-EWING | null | null | 280027880 | EURO-EWING |
| 280010315 | 280005726 | 1.74 | 78 | Palliative (P) | 2019-02-09 | 2019-02-16 | GEMCITABINE | 02 | N | 280027899 | GEMCITABINE |
| 280010316 | 280005729 | 1.76 | 84 | Curative (C) | 2018-04-23 | 2018-05-31 | Oxaliplatin + Modified de Gramont | 2 | N | 280027903 | OXALIPLATIN + MDG |
| 280010317 | 280005732 | 1.77 | 65.6 | Neo-adjuvant (N) | 2015-12-31 | 2016-01-01 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280027908 | CETUXIMAB + CISPLATIN + FU |
| 280010318 | 280005733 | 1.73 | 74 | Palliative (P) | 2016-10-03 | 2016-10-03 | VAI (Ifos 3g/m2) | null | null | 280027914 | IRINOTECAN + TEMOZOLOMIDE |
| 280010319 | 280005734 | 1.71 | null | null | 2017-08-15 | 2017-08-29 | VAI (Ifos 3g/m2) | N | N | 280027914 | IRINOTECAN + MDG |
| 280010320 | 280005737 | 1.77 | 82.4 | Neo-adjuvant (N) | 2013-03-25 | 2013-03-28 | Oxaliplatin + Modified de Gramont | N | N | 280027926 | OXALIPLATIN + MDG |
| 280010321 | 280005741 | 1.62 | 46.6 | Palliative (P) | null | 2014-08-03 | EURO-EWING | 02 | N | 280027927 | EURO-EWING |
| 280010322 | 280005743 | 1.6 | 72.5 | Neo-adjuvant (N) | null | 2018-08-31 | VAI (Ifos 3g/m2) | null | null | 280027930 | IRINOTECAN + MDG |
| 280010323 | 280005744 | null | null | Neo-adjuvant (N) | 2016-08-13 | 2016-09-24 | CARBOPLATIN + PACLITAXEL | N | N | 280027931 | CARBOPLATIN + PACLITAXEL |
| 280010324 | 280005746 | 1.77 | 84.7 | Palliative (P) | 2014-04-12 | 2014-05-13 | Etoposide + Ifosfamide (3 days) | N | N | 280027969 | ETOPOSIDE + IFOSFAMIDE |
| 280010325 | 280009014 | null | 66.2 | Palliative (P) | 2013-08-31 | 2013-08-31 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280027969 | CARBOPLATIN + ETOPOSIDE |
| 280010326 | 280005754 | 1.77 | 81.6 | Palliative (P) | 2014-10-28 | 2015-04-25 | DE-ESCALATE TRIAL | N | N | 280027992 | DE-ESCALATE TRIAL |
| 280010327 | 280009017 | 1.81 | 43.7 | Adjuvant (A) | 2017-09-25 | 2017-10-14 | CISPLATIN + FLUOROURACIL | 02 | N | 280027992 | CISPLATIN + FLUOROURACIL |
| 280010328 | 280005757 | null | 68 | Curative (C) | 2017-12-24 | 2017-12-24 | DE-ESCALATE TRIAL | null | null | 280028006 | DE-ESCALATE TRIAL |
| 280010329 | 280009019 | null | 72.4 | Neo-adjuvant (N) | null | 2017-09-11 | IRINOTECAN + TEMOZOLOMIDE | N | N | 280028009 | IRINOTECAN + TEMOZOLOMIDE |
| 280010330 | 280009020 | null | 89.6 | Curative (C) | 2015-04-22 | 2015-05-05 | Doxorubicin + Ifosfamide | 2 | null | 280028015 | DOXORUBICIN + IFOSFAMIDE |
| 280010331 | 280005766 | 1.74 | 73.5 | Palliative (P) | 2018-03-25 | 2018-03-29 | Gemcitabine day 1&8 | 02 | N | 280028023 | GEMCITABINE |
| 280010332 | 280005771 | 1.7 | 88 | Adjuvant (A) | null | 2015-09-06 | Irinotecan + Modified De Gramont | N | null | 280028032 | IRINOTECAN + MDG |
| 280010333 | 280005773 | 1.82 | 52.8 | Neo-adjuvant (N) | 2016-03-18 | 2016-03-18 | CAV | N | N | 280028045 | CAV |
| 280010334 | 280009026 | 1.61 | 66 | Palliative (P) | 2016-09-20 | 2017-05-01 | GEMCITABINE | N | N | 280028059 | GEMCITABINE |
| 280010335 | 280005776 | 1.86 | 89.55 | Curative (C) | null | 2015-06-21 | Oxaliplatin + Modified de Gramont | null | null | 280028063 | OXALIPLATIN + MDG |
| 280010336 | 280005778 | 1.73 | 97 | Palliative (P) | 2014-07-24 | 2014-12-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280028065 | CARBOPLATIN + PACLITAXEL |
| 280010337 | 280005780 | 1.68 | 8.5 | Palliative (P) | 2013-07-15 | 2013-07-22 | EW EuroEwing 99 : VActI | null | null | 280028075 | EURO-EWING |
| 280010338 | 280005786 | 1.68 | 62.5 | Palliative (P) | 2013-11-23 | 2013-11-28 | CAV | null | null | 280028086 | CAV |
| 280010339 | 280009030 | 1.7 | 55.8 | Palliative (P) | 2017-04-22 | 2017-04-27 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 280028090 | EURO-EWING |
| 280010340 | 280005791 | null | 79 | Palliative (P) | 2017-11-10 | 2018-01-28 | Oxaliplatin + Modified de Gramont | 02 | N | 280028096 | OXALIPLATIN + MDG |